SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.530
+0.060 (1.73%)
At close: Apr 28, 2026, 4:00 PM EDT
3.500
-0.030 (-0.85%)
After-hours: Apr 28, 2026, 6:20 PM EDT
SAB Biotherapeutics Employees
SAB Biotherapeutics had 86 employees as of December 31, 2025. The number of employees increased by 23 or 36.51% compared to the previous year.
Employees
86
Change (1Y)
23
Growth (1Y)
36.51%
Revenue / Employee
n/a
Profits / Employee
$49,550
Market Cap
248.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Adagene | 128 |
| Arcturus Therapeutics Holdings | 111 |
| Artiva Biotherapeutics | 104 |
| Orchestra BioMed Holdings | 86 |
| Camp4 Therapeutics | 48 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
SABS News
- 6 days ago - SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 - GlobeNewsWire
- 5 weeks ago - SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 5 weeks ago - SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 6 weeks ago - SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes - GlobeNewsWire
- 7 weeks ago - SAB BIO Reports Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 weeks ago - SAB Biotherapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire